Reviva Pharmaceuticals HoldiRVPH
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 35 institutions reported holding Reviva Pharmaceuticals Holdi (RVPH) in their 13F filings, up 34 from Q4 2025. 12 opened new positions and 1 sold out. The largest holders were Millennium Management ($579K), Highbridge Capital Management LLC ($556K) and Armistice Capital, LLC ($432K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Reviva Pharmaceuticals Holdi
- CUSIP
- 76152G209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $1.3M |
| Exits | 1 | $190K |
All 13F filers, Q4 2025 → Q1 2026: 2,531,919 shares bought and 55,151 shares sold, net +2,476,768 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Millennium Management | 0.00% | Add +601.5% | 793,948 | $579K |
| Highbridge Capital Management LLC | 0.05% | New | 762,236 | $556K |
| Armistice Capital, LLC | 0.01% | New | 592,079 | $432K |
| Gsa Capital Partners LLP | 0.01% | New | 261,898 | $191K |
| Vanguard Capital Management LLC | 0.00% | — | 117,568 | $86K |
| Warberg Asset Management LLC | 0.14% | New | 90,772 | $66K |
| Geode Capital Management, LLC | 0.00% | Add +39.2% | 72,992 | $53K |
| Renaissance Technologies | 0.00% | New | 43,002 | $31K |
| Virtu Financial LLC | 0.00% | New | 32,905 | $24K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 31,598 | $23K |
| State Street Corp. | 0.00% | No change | 19,160 | $14K |
| BlackRock, Inc. | 0.00% | No change | 18,582 | $14K |
| HRT Financial LP | 0.00% | Add +1084.3% | 18,423 | $13K |
| Castleview Partners, LLC | 0.01% | New | 15,694 | $11K |
| Two Sigma Investments, LP | 0.00% | Add +1446.8% | 10,715 | $8K |
| Northern Trust Corp. | 0.00% | No change | 10,469 | $8K |
| Morgan Stanley | 0.00% | Reduce -49.4% | 8,530 | $6K |
| UBS Group AG | 0.00% | Reduce -70.7% | 5,269 | $4K |
| Vanguard Global Advisers, LLC | 0.00% | — | 3,115 | $2K |
| Group One Trading LLC | 0.00% | Reduce -0.3% | 3,109 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,193 | $2K |
| Sound Income Strategies, LLC | 0.00% | New | 1,500 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 1,219 | $889 |
| Larson Financial Group LLC | 0.00% | No change | 833 | $608 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 625 | $498 |
| Northwestern Mutual Wealth Management Co. | 0.00% | Add +1.1% | 470 | $343 |
| Purpose Unlimited Inc. | 0.00% | No change | 405 | $288 |
| SBI Securities Co., Ltd. | 0.00% | No change | 250 | $182 |
| IFP Advisors, Inc | 0.00% | New | 200 | $146 |
| Wells Fargo & Company | 0.00% | No change | 150 | $109 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 50 | $40 |
| Activest Wealth Management | 0.00% | No change | 50 | $36 |
| Tradewinds Capital Management, LLC | 0.00% | Add +4.0% | 13 | $10 |
| Danske Bank A/S | 0.00% | New | 7 | $5 |
| Royal Bank of Canada | 0.00% | No change | 75 | $0 |
"% of holder's portfolio" is RVPH's weight in each manager's 13F, not the share of Reviva Pharmaceuticals Holdi the manager owns.